Picture biomindz Mainz Biomed LSE Colorectal Cancer Screening 650x100px

Organisation › Details

Incyte Corporation (Nasdaq: INCY)

https://www.incyte.com

Incyte is a Wilmington, Delaware-based drug discovery and development company with a growing pipeline of oral compounds to treat HIV, inflammation, cancer and diabetes. *

	Group	Incyte Corporation (Group)
	Predecessor	Incyte Genomics Inc.
	Industry	genomics/genetics

	Street	Experimental Station, Route 141 & Henry Clay Road, Bldg. E336
	City	19880 Wilmington, DE
	Tel	+1-302-498-6700
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	34,440,000 (revenue, consolidated (2007) 2007-12-31)
	Profit	-86,881,000 (2007-12-31)
	Cash	257,327,000 (2007-12-31)

		* Document for »About Section«:

		Record changed: 2024-11-24

More documents for Incyte Corporation (Group)

[1] Innate Pharma S.A.. (10/14/24). "Press Release: Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board"....
[2] Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres....
[3] MorphoSys AG. (5/3/23). "Press Release: MorphoSys AG Reports First Quarter 2023 Financial Results". Planegg....
[4] MorphoSys AG. (8/26/21). "Press Release: MorphoSys and Incyte Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma". Plan...
[5] MorphoSys AG. (8/17/21). "Press Release: MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China". Planegg....
[6] Crescendo Biologics Ltd.. (5/10/21). "Press Release: Crescendo Biologics further Strengthens Leadership Team with Appointment of Dr Michael Booth as Chief Financial Officer". Cambridge....
[7] MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE....
[8] iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]